From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology Dahkki Jean-Michel Dayer

Viečča ollesdeavstta

Introduction to “Synovitis – an inflammation of joints destroying the bone” Dahkki Costantino Pitzalis, Douglas Veale, Jean-Michel Dayer

Viečča ollesdeavstta

A Brief History of IL-1 and IL-1 Ra in Rheumatology Dahkki Jean-Michel Dayer, Francesca Oliviero, Leonardo Punzi

Viečča ollesdeavstta

Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment Dahkki François Chasset, Jean-Michel Dayer, Carlo Chizzolini

Viečča ollesdeavstta

Editorial: IL-1 Inhibition Dahkki Francesca Oliviero, Paolo Sfriso, Leonardo Punzi, Jean-Michel Dayer

Viečča ollesdeavstta

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins? Dahkki Nicolas Vuilleumier, Jean-Michel Dayer, Arnold Von Eckardstein, Pascale Roux-Lombard

Viečča ollesdeavstta

Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes. Dahkki Lyssia Gruaz, Céline Delucinge-Vivier, Patrick Descombes, Jean-Michel Dayer, Danielle Burger

Viečča ollesdeavstta

The period length of fibroblast circadian gene expression varies widely among human individuals. Dahkki Steven A Brown, Fabienne Fleury-Olela, Emi Nagoshi, Conrad Hauser, Cristiana Juge, Christophe A Meier, Rachel Chicheportiche, Jean-Michel Dayer, Urs Albrecht, Ueli Schibler

Viečča ollesdeavstta